Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carlos Almonacid

Showing results (1-10 of 40) with videos related to

Pageof 4
Sort By:
Archivos De Bronconeumologia|September 2, 2006
[Systemic and lung inflammation in 2 phenotypes of chronic obstructive pulmonary disease]José Luis Izquierdo, Carlos Almonacid, Trinidad Parra, et al.
Journal of Personalized Medicine|July 25, 2025
BALF Lymphocyte and Cytokine Profiling as Biomarkers of Acute Rejection After Lung TransplantationSilvia Aguado Ibáñez, Carlos Almonacid Sanchez, Piedad Ussetti Gil
Archivos De Bronconeumologia|November 28, 2006
[Epidemiology of lung cancer in Spain and forecast for the future]Ignacio Sánchez Hernández, José Luis Izquierdo Alonso, Carlos Almonacid Sánchez
Open Respiratory Archives|April 24, 2026
[Knowledge and attitudes about social determinants of respiratory health in SEPAR members]Joan B Soriano, Carlos Almonacid, Isabel Urrutia-Landa, et al.
BMC Pulmonary Medicine|January 4, 2023
Geographical differences in the use of oral corticosteroids in patients with severe asthma in Spain: heat map based on existing databases analysesCarlos Almonacid, Eunice Fitas, Joaquín Sánchez-Covisa, et al.
Journal of Asthma and Allergy|January 3, 2025
Evaluation Checklist for the Multidisciplinary Approach to Patients with Asthma or Suspected Asthma in United Airway DiseaseCarlos Almonacid, Pilar Ausín, José Miguel Villacampa, et al.
Archivos De Bronconeumologia|December 20, 2025
Inside GEMA 5.5: Expert Insights on the Latest Changes in Asthma ManagementCarlos Almonacid, Santiago Quirce, Marina Blanco, et al.
Journal of Investigational Allergology & Clinical Immunology|April 10, 2026
Artificial Intelligence in Asthma: From Diagnosis to ManagementCarlos Almonacid, Ignacio Dávila, Vicente Plaza, et al.
International Journal of Chronic Obstructive Pulmonary Disease|October 23, 2014
Impact of COPD in patients with lung cancer and advanced disease treated with chemotherapy and/or tyrosine kinase inhibitorsJosé Luis Izquierdo, Pilar Resano, Abdulkader El Hachem, et al.
ERJ Open Research|August 19, 2022
Real-life burden of hospitalisations due to COPD exacerbations in SpainJosé Luis Izquierdo, José Miguel Rodríguez, Carlos Almonacid, et al.
Pageof 4

Showing results (1-10 of 40) with videos related to

Sort By:
Pageof 4
Archivos De Bronconeumologia|September 2, 2006
[Systemic and lung inflammation in 2 phenotypes of chronic obstructive pulmonary disease]José Luis Izquierdo, Carlos Almonacid, Trinidad Parra, et al.
Journal of Personalized Medicine|July 25, 2025
BALF Lymphocyte and Cytokine Profiling as Biomarkers of Acute Rejection After Lung TransplantationSilvia Aguado Ibáñez, Carlos Almonacid Sanchez, Piedad Ussetti Gil
Archivos De Bronconeumologia|November 28, 2006
[Epidemiology of lung cancer in Spain and forecast for the future]Ignacio Sánchez Hernández, José Luis Izquierdo Alonso, Carlos Almonacid Sánchez
Open Respiratory Archives|April 24, 2026
[Knowledge and attitudes about social determinants of respiratory health in SEPAR members]Joan B Soriano, Carlos Almonacid, Isabel Urrutia-Landa, et al.
BMC Pulmonary Medicine|January 4, 2023
Geographical differences in the use of oral corticosteroids in patients with severe asthma in Spain: heat map based on existing databases analysesCarlos Almonacid, Eunice Fitas, Joaquín Sánchez-Covisa, et al.
Journal of Asthma and Allergy|January 3, 2025
Evaluation Checklist for the Multidisciplinary Approach to Patients with Asthma or Suspected Asthma in United Airway DiseaseCarlos Almonacid, Pilar Ausín, José Miguel Villacampa, et al.
Archivos De Bronconeumologia|December 20, 2025
Inside GEMA 5.5: Expert Insights on the Latest Changes in Asthma ManagementCarlos Almonacid, Santiago Quirce, Marina Blanco, et al.
Journal of Investigational Allergology & Clinical Immunology|April 10, 2026
Artificial Intelligence in Asthma: From Diagnosis to ManagementCarlos Almonacid, Ignacio Dávila, Vicente Plaza, et al.
International Journal of Chronic Obstructive Pulmonary Disease|October 23, 2014
Impact of COPD in patients with lung cancer and advanced disease treated with chemotherapy and/or tyrosine kinase inhibitorsJosé Luis Izquierdo, Pilar Resano, Abdulkader El Hachem, et al.
ERJ Open Research|August 19, 2022
Real-life burden of hospitalisations due to COPD exacerbations in SpainJosé Luis Izquierdo, José Miguel Rodríguez, Carlos Almonacid, et al.
Pageof 4